about
Gene expression analysis of human red blood cells(-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans.Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humansCocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivoNO detection in biological samples: differentiation of 14 NO and 15 NO using infrared laser spectroscopy.No evidence for activated autophagy in left ventricular myocardium at early reperfusion with protection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting.Characterization of the non-invasive assessment of the cutaneous microcirculation by laser Doppler perfusion scanner.Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial.Indexes of NO bioavailability in human blood.Release of Intracoronary Microparticles during Stent Implantation into Stable Atherosclerotic Lesions under Protection with an Aspiration Device.Intraaortic Protection From Embolization in Patients Undergoing Transaortic Transcatheter Aortic Valve Implantation.No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: Interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial.Comparison of the simple red blood cell adhesiveness/aggregation test with the laser-assisted optical rotational cell analyzer: Red blood cell aggregation in patients with coronary artery disease and a healthy control group.Circulating NO pool in humans.Flavanols and cardiovascular health: effects on the circulating NO pool in humans.Endothelial function, nitric oxide, and cocoa flavanols.The measurement of blood and plasma nitrite by chemiluminescence: pitfalls and solutions.Coronary aspirate TNFα reflects saphenous vein bypass graft restenosis risk in diabetic patients.The L-arginine nitric oxide pathway: avenue for a multiple-level approach to assess vascular function.Recent methodological advances in the analysis of nitrite in the human circulation: nitrite as a biochemical parameter of the L-arginine/NO pathway.Aspirate from human stented saphenous vein grafts induces epicardial coronary vasoconstriction and impairs perfusion and left ventricular function in rat bioassay hearts with pharmacologically induced endothelial dysfunction.RBC NOS: regulatory mechanisms and therapeutic aspects.Reductive gas-phase chemiluminescence and flow injection analysis for measurement of the nitric oxide pool in biological matrices.Kinetics and Signal Activation Properties of Circulating Factor(s) From Healthy Volunteers Undergoing Remote Ischemic Pre-Conditioning.Coronary microembolization: from bedside to bench and back to bedside.TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure.Lessons from human coronary aspirate.The coronary circulation in cardioprotection: more than just one confounder.Calcium antagonists in myocardial ischemia/reperfusion--update 2012.Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction.Cardioprotection by remote ischemic conditioning and its signal transduction.lschemic preconditioning in pigs: a causal role for signal transducer and activator of transcription 3.Evidence for in vivo transport of bioactive nitric oxide in human plasma.Confounders of Cardioprotection by Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting.Proteomics/phosphoproteomics of left ventricular biopsies from patients with surgical coronary revascularization and pigs with coronary occlusion/reperfusion: remote ischemic preconditioning.Potential humoral mediators of remote ischemic preconditioning in patients undergoing surgical coronary revascularization.Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning.Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia.Short-term effect of the HMG-CoA reductase inhibitor rosuvastatin on erythrocyte nitric oxide synthase activity.
P50
Q22305349-ABA53AB2-0E38-4528-BBEF-868B2B2CDD59Q24536110-F43253F0-F48B-467B-95A6-597A498CC18DQ28291854-5223C2FE-E6C6-4A1A-A047-66D69DFA82C1Q28565952-6858ECF0-FFF9-47B0-B733-C6C0CC9F0211Q33327445-C0A38702-DE0D-4464-A7B5-E751650D9B05Q33568009-3E1B9F01-F869-4744-9984-2CAEDB8BFA7AQ33629235-93535F08-002A-4BC8-AF81-9D216A817F3CQ34364666-E4D4623E-E32F-4899-B472-69B21454D882Q34998608-0F4158B2-D0D1-4AD9-B56F-B359B942130DQ35542818-AF62D4B6-6956-4863-86C5-CF9ADDDB0C9DQ35733693-53CC8BAB-15E5-474E-A1DB-835707E075FCQ36219573-CC6FA6D7-F863-476A-9EE1-84FF02ACF3F4Q36226554-EDEC7463-FCE6-4010-AE1C-4DD4DCC41FA9Q36420246-67F6F67A-6A58-4FD4-BACE-954637C3AC2EQ36516312-1384431C-8E36-46D3-9F98-36AB338485C3Q36516317-93EF6FEC-2033-49AB-A5D1-F1867C21B444Q36545307-47BC6D07-47FD-4E58-B4B2-3A60DB47CA0CQ36576204-C9991FD4-C4B3-4FA5-A0EF-458E3D03717CQ36642725-FE854586-1961-423E-AC0A-0144025ECF4EQ36753946-6E94A594-E8C9-43DA-A832-D244BB495C3FQ37176710-57EEB9D4-3227-4E4C-BE54-3F72828DEC92Q37186267-ED72D10D-2BD7-4D62-9E03-3D198D2CEDF9Q37191440-EE1347FE-E535-4E94-8A8E-59A9D45C86D9Q37234246-63F21B60-EE42-4A66-A3D2-26BBF863641FQ37626321-6A7EA1E0-8DFF-4A25-8035-9C811E76DA84Q37767172-D401A907-791F-4B8F-8772-7AC45D854B13Q37771751-87264E43-4071-4798-BA9A-00094E8C2491Q37901592-1E5CD3E0-28B9-4909-BFEE-1DC7DE9D1B58Q37946255-B974C159-1835-4D4F-BD6A-AAF73B1B789CQ38018510-C10BCB24-EEAD-4DCC-938E-73608B97151EQ38797276-C44DA5CE-4BCB-431E-B4B8-0A8161994426Q39032510-9B50095A-693F-43FE-8689-A43A64706977Q39048983-5790B89D-A27F-4214-9290-8C15D5CCDB7EQ39737864-E9FEF51A-3CD5-4AE7-98E6-8D5F7ACA8DD4Q41150694-1922ABE6-A3F7-4EFB-BC28-DD00F9BFDDCFQ41332091-8FD3120D-2125-4169-BF78-C0755BA7509DQ42039904-A31C562A-92D1-439A-95AF-59111CEB7711Q42318959-549D4103-57C8-4FCF-8CE5-2F912E3A5FCCQ42507487-6C1354A1-B751-4D7C-941E-7AAD032A7BAFQ43186717-BD1B8EE9-A913-4261-85EB-820A66A84F98
P50
name
Petra Kleinbongard
@en
type
label
Petra Kleinbongard
@en
prefLabel
Petra Kleinbongard
@en